261 related articles for article (PubMed ID: 24690765)
1. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.
Yi X; Long L; Yang C; Lu Y; Cheng M
PLoS One; 2014; 9(4):e93599. PubMed ID: 24690765
[TBL] [Abstract][Full Text] [Related]
2. Differential effects between maotai and ethanol on hepatic gene expression in mice: Possible role of metallothionein and heme oxygenase-1 induction by maotai.
Liu J; Cheng ML; Shi JZ; Yang Q; Wu J; Li CX; Waalkes MP
Exp Biol Med (Maywood); 2006 Oct; 231(9):1535-41. PubMed ID: 17018877
[TBL] [Abstract][Full Text] [Related]
3. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and histopathological study of relevance of Guizhou Maotai liquor and liver diseases.
Wu J; Cheng ML; Zhang GH; Zhai RW; Huang NH; Li CX; Luo TY; Lu S; Yu ZQ; Yao YM; Zhang YY; Ren LZ; Ye L; Li L; Zhang HN
World J Gastroenterol; 2002 Jun; 8(3):571-4. PubMed ID: 12046095
[TBL] [Abstract][Full Text] [Related]
5. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Memon A; Pyao Y; Jung Y; Lee JI; Lee WK
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751728
[TBL] [Abstract][Full Text] [Related]
6. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
[TBL] [Abstract][Full Text] [Related]
7. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.
Yan G; Wang X; Sun C; Zheng X; Wei H; Tian Z; Sun R
Sci Rep; 2017 May; 7(1):2567. PubMed ID: 28566719
[TBL] [Abstract][Full Text] [Related]
8. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
[TBL] [Abstract][Full Text] [Related]
9. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.
Brandon-Warner E; Walling TL; Schrum LW; McKillop IH
Alcohol Clin Exp Res; 2012 Apr; 36(4):641-53. PubMed ID: 22017344
[TBL] [Abstract][Full Text] [Related]
10. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
Nasr M; Selima E; Hamed O; Kazem A
Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
[TBL] [Abstract][Full Text] [Related]
11. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
12. Essential roles of ERKs and p38K in up-regulation of GST A1 expression by Maotai content in human hepatoma cell line Hep3B.
Zhang D; Lu H; Li J; Shi X; Huang C
Mol Cell Biochem; 2006 Dec; 293(1-2):161-71. PubMed ID: 16786188
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
14. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
15. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
[TBL] [Abstract][Full Text] [Related]
16. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
17. Effect of Maotai liquor on the liver: an experimental study.
Cheng ML; Wu J; Zhang WS; Wang HQ; Li CX; Huang NH; Yao YM; Ren LG; Ye L; Li L
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):93-8. PubMed ID: 14969847
[TBL] [Abstract][Full Text] [Related]
18. Dietary modulations of folic acid affect the development of diethylnitrosamine induced hepatocellular carcinoma in a rat model.
Sharma R; Ali T; Negi I; Das A; Duseja A; Kaur J
J Mol Histol; 2021 Apr; 52(2):335-350. PubMed ID: 33438102
[TBL] [Abstract][Full Text] [Related]
19. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats.
Ibrahim S; Fahim SA; Tadros SA; Badary OA
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23078. PubMed ID: 35437842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
